SARS-CoV-2 spike proteins react with Au and Si, are electrically conductive and denature at 3 × 108 V m−1: a surface bonding and a single-protein circuit study
Developing means to characterise SARS-CoV-2 and its new variants is critical for future outbreaks. SARS-CoV-2 spike proteins have peripheral disulfide bonds (S-S), which are common in all spike proteins of SARS-CoV-2 variants, in other types of coronaviruses (e.g., SARS-CoV and MERS-CoV) and are lik...
| Main Authors: | Dief, E.M., Darwish, Nadim |
|---|---|
| Format: | Journal Article |
| Language: | English |
| Published: |
2023
|
| Online Access: | http://purl.org/au-research/grants/arc/DP190100735 http://hdl.handle.net/20.500.11937/94742 |
Similar Items
Antiviral potential of selenium complexes from Brassicaceae by inhibiting protein bond between MAP4 and the spike of SARS-CoV-2
by: Ilmiyah, Silvi Z., et al.
Published: (2024)
by: Ilmiyah, Silvi Z., et al.
Published: (2024)
Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting
by: Lim, Hui Xuan *, et al.
Published: (2022)
by: Lim, Hui Xuan *, et al.
Published: (2022)
The SARS-CoV-2 variants and their impacts
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2022)
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2022)
Virus-like particles of nodavirus displaying the receptor binding domain of SARS-CoV-2 spike protein: a potential VLP-based COVID-19 vaccine
by: Kumar, Kiven, et al.
Published: (2023)
by: Kumar, Kiven, et al.
Published: (2023)
Genomic epidemiology of SARS-CoV-2 in Malaysia
by: Chew, Sian Hui
Published: (2025)
by: Chew, Sian Hui
Published: (2025)
Pathophysiology, histopathology and therapeutic of SARS-CoV-2
by: Noman, Efaq, et al.
Published: (2020)
by: Noman, Efaq, et al.
Published: (2020)
Lateral flow immunoassays for SARS-CoV-2
by: Ang, Geik Yong, et al.
Published: (2022)
by: Ang, Geik Yong, et al.
Published: (2022)
In silico selection of aptamers against SARS-CoV-2
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2024)
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2024)
Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
by: Chan, Lee-Chin, et al.
Published: (2023)
by: Chan, Lee-Chin, et al.
Published: (2023)
The cell mediated and humoral response to SARS-CoV-2 infection
by: Burns, Eleanor
Published: (2022)
by: Burns, Eleanor
Published: (2022)
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
by: Lim, Hui Xuan *, et al.
Published: (2021)
by: Lim, Hui Xuan *, et al.
Published: (2021)
Thermophoretic collection of virus-laden (SARS-CoV-2) aerosols
by: Zhang, Xiangzhi, et al.
Published: (2021)
by: Zhang, Xiangzhi, et al.
Published: (2021)
SARS-CoV-2 screening must go beyond sick
by: Abdullah, Syahril
Published: (2020)
by: Abdullah, Syahril
Published: (2020)
Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia
by: Ummu Afeera, Zainulabid, et al.
Published: (2022)
by: Ummu Afeera, Zainulabid, et al.
Published: (2022)
Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia
by: Zainulabid, Ummu Afeera, et al.
Published: (2022)
by: Zainulabid, Ummu Afeera, et al.
Published: (2022)
Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy
by: Lee, Vanessa W., et al.
Published: (2024)
by: Lee, Vanessa W., et al.
Published: (2024)
SARS-CoV-2: from origin to treatment and control management strategies
by: Hezam, Kamal, et al.
Published: (2020)
by: Hezam, Kamal, et al.
Published: (2020)
Risk Perceptions of SARS-CoV-2 in the UK: A City-wise Analysis
by: Raza, Naba
Published: (2022)
by: Raza, Naba
Published: (2022)
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz, Al-Fattah Yahaya *, et al.
Published: (2023)
by: Abdul Aziz, Al-Fattah Yahaya *, et al.
Published: (2023)
Development of multi-epitope peptide-based vaccines against SARS-CoV-2
by: Lim, Hui Xuan *, et al.
Published: (2020)
by: Lim, Hui Xuan *, et al.
Published: (2020)
NK cells: A double edge sword against SARS-CoV-2
by: Masselli, E., et al.
Published: (2020)
by: Masselli, E., et al.
Published: (2020)
Concerns regarding SARS-CoV-2 JN.1 mutations should be raised
by: Roney, Miah, et al.
Published: (2024)
by: Roney, Miah, et al.
Published: (2024)
SARS-CoV-2 infection and human semen: possible modes of contamination and transmission
by: Bhattacharya, Koushik, et al.
Published: (2021)
by: Bhattacharya, Koushik, et al.
Published: (2021)
Does the sars-cov-2 spike protein receptor binding domain interact effectively with the dpp4 (Cd26) receptor? A molecular docking study
by: Cameron, Kirsten, et al.
Published: (2021)
by: Cameron, Kirsten, et al.
Published: (2021)
Apa yang berlaku pada tubuh apabila berlaku jangkitan SARS-CoV-2 ?
by: Mohd Nasir, Mohd Hamzah
Published: (2020)
by: Mohd Nasir, Mohd Hamzah
Published: (2020)
Isolation and characterisation of bovine ultralong antibodies to SARS-CoV-2 using phage display
by: Park, Emily
Published: (2024)
by: Park, Emily
Published: (2024)
Protein denaturation in pilot scale spray dryer
by: Kioh, Shin Fang
Published: (2010)
by: Kioh, Shin Fang
Published: (2010)
A Fog Computing-based System to Identify SARS - CoV -2 Using Deep Learning
by: Welhenge, Anuradhi
Published: (2021)
by: Welhenge, Anuradhi
Published: (2021)
Identification of SARS-CoV-2 inhibitors from alkaloids using molecular modeling and in silico approaches
by: Roni, Md Abul Hasan, et al.
Published: (2023)
by: Roni, Md Abul Hasan, et al.
Published: (2023)
Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: from alpha to Omicron
by: Choo, Yee Yu, et al.
Published: (2022)
by: Choo, Yee Yu, et al.
Published: (2022)
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection
by: Romani, Arianna, et al.
Published: (2023)
by: Romani, Arianna, et al.
Published: (2023)
Maternal immune activation as a risk factor for psychiatric illness in the context of the SARS-CoV-2 pandemic
by: Lins, Brittney
Published: (2021)
by: Lins, Brittney
Published: (2021)
Construction of multi-epitopes vaccine candidate against SARS-CoV-2 D614G variant
by: Siti Asmaa Mat Jusoh,, et al.
Published: (2022)
by: Siti Asmaa Mat Jusoh,, et al.
Published: (2022)
Increasing Sporadic Covid-19 Cases:Should We Heed Airborne Transmission Of SARS-CoV-2?
by: Ahmad Mahfuz, Gazali
Published: (2021)
by: Ahmad Mahfuz, Gazali
Published: (2021)
Increasing sporadic Covid-19 cases:should we heed airborne transmission of SARS-CoV-2?
by: Ahmad Mahfuz, Gazali
Published: (2021)
by: Ahmad Mahfuz, Gazali
Published: (2021)
Evolution of SARS-CoV-2 from BA.2.86 to JN.1 variations and detection in Bangladesh
by: Roney, Miah, et al.
Published: (2024)
by: Roney, Miah, et al.
Published: (2024)
Humoral response to SARS-CoV-2 vaccines among healthcare workers in a tertiary hospital in Malaysia
by: Mohd Amin, Amrina, et al.
Published: (2022)
by: Mohd Amin, Amrina, et al.
Published: (2022)
Elucidating conserved sub-units from beta-coronavirus species for the creation of novel, cross-clade, and
stable chimera sars-cov-2 spike proteins as future proof vaccine candidates
by: Susu, Wang
Published: (2023)
by: Susu, Wang
Published: (2023)
Thermal Denaturation Kinetics of Whey Protein and Maltodextrin Mixture
by: Nuraini, Mohd Yusoff, et al.
Published: (2013)
by: Nuraini, Mohd Yusoff, et al.
Published: (2013)
Analytical quantification method of protein denaturation in spray drying
by: Suria, Mahmud
Published: (2012)
by: Suria, Mahmud
Published: (2012)
Similar Items
-
Antiviral potential of selenium complexes from Brassicaceae by inhibiting protein bond between MAP4 and the spike of SARS-CoV-2
by: Ilmiyah, Silvi Z., et al.
Published: (2024) -
Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting
by: Lim, Hui Xuan *, et al.
Published: (2022) -
The SARS-CoV-2 variants and their impacts
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2022) -
Virus-like particles of nodavirus displaying the receptor binding domain of SARS-CoV-2 spike protein: a potential VLP-based COVID-19 vaccine
by: Kumar, Kiven, et al.
Published: (2023) -
Genomic epidemiology of SARS-CoV-2 in Malaysia
by: Chew, Sian Hui
Published: (2025)